Traws Pharma, Inc. (TRAW) — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024)

$226.0K

Net Income/Loss (FY2024)

-$166.5M

Total Assets (FY2024)

$25.0M

Total Equity (FY2024)

-$31.6M

Cash Flows from Operating Activities (FY2024)

-$29.8M

Source: Traws Pharma, Inc. 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.